Does Elanco own Seresto
Yes, Elanco does own Seresto. Elanco is an animal health company and Seresto is a flea and tick control product developed by Elanco. It uses two active ingredients, imidacloprid and flumethrin, to repel and kill fleas and ticks for up to 8 months. It’s easy to apply with a buckle-like closure on the collar that fits around any dog or cat’s neck and it starts working within 48 hours of application. Since 2018, Elanco has owned Seresto, which they began selling online in 2020. They also offer rebates for purchasing Seresto as well as frequent promotions to make it more accessible for pet owners.
What Is Elanco?
Elanco is an international animal health company based in Indiana, United States. It was originally founded in 1954 as a division of Eli Lilly and Company, which is one of the world’s largest pharmaceutical companies. Elanco provides products and services that enhance animal health and well-being, food safety, and nutrition.
Elanco’s offerings include prescription medicines, over-the-counter products, vitamins, specialty nutritional supplements, flea and tick treatments (such as Seresto), as well as a line of feed additives. The company also provides support services such as diagnostic testing and laboratory analysis. In addition to providing prevention for common infectious diseases in animals, Elanco also focuses on technologies to improve animal production systems worldwide.
Who Owns Seresto?
The Seresto product is owned by Elanco, an animal health company based in the United States. Elanco was founded serestocollars company as part of Eli Lilly and Company in 1954 and was spun off into its own independent business in 2006.
Today, Elanco has a strong presence in many different animal health markets, including pet drugs, vaccines, nutrition products and flea and tick treatments. In 2018, they acquired the German pharmaceuticals company Boehringer Ingelheim Vetmedica for $7.6 billion dollars. This purchase included their popular Seresto collar brand which protects cats and dogs from parasites both indoors and outdoors for up to 8 months at a time.
Elanco’s mission statement says that they strive to “empower those who raise and care for animals to advance wellbeing through solutions grounded in science.” With this goal in mind, it makes sense that they would acquire products like Seresto that can help meet these needs!
What Is the Relationship Between Elanco and Seresto?
The relationship between Elanco and Seresto is one of owner and product. Elanco, previously known as Eli Lilly and Company, acquired Seresto in 2015. The acquisition was part of Elanco’s strategy to expand its presence in the petcare and veterinary sectors.
Seresto is a flea-and-tick collar for cats and dogs that uses the active ingredient imidacloprid to provide up to eight months of pest protection from fleas, ticks, lice, mites and other pests. The company also produces companion medications such as heartworm control pills and oral flea medications for cats and dogs.
Elanco now has a broad range of products in the pet healthcare market thanks to its relationship with Seresto. In addition to offering innovative products like Seresto, Elanco takes research seriously when creating pet health solutions. Their research team looks at current market trends to create solutions that support the preferred lifestyle preferences of today’s pet owners while still focusing on safety of their animal companions first.
Finals
Elanco does not own Seresto; however, the company has collaborated with them by providing steep discounts on their products to pet owners throughout North America. The ultimate objective of this partnership was to improve pet health worldwide.